HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 205 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,251 | +263.9% | 2,571 | +290.7% | 0.00% | +200.0% |
| Q2 2023 | $23,155 | +13131.4% | 658 | -87.7% | 0.00% | -83.3% |
| Q1 2023 | $175 | +1150.0% | 5,367 | +1895.2% | 0.01% | +500.0% |
| Q4 2022 | $14 | -100.0% | 269 | -86.1% | 0.00% | 0.0% |
| Q3 2022 | $86,000 | +26.5% | 1,938 | +39.5% | 0.00% | -50.0% |
| Q2 2022 | $68,000 | +385.7% | 1,389 | +394.3% | 0.00% | – |
| Q1 2022 | $14,000 | -33.3% | 281 | -41.9% | 0.00% | – |
| Q4 2021 | $21,000 | +23.5% | 484 | +8.5% | 0.00% | – |
| Q3 2021 | $17,000 | -64.6% | 446 | -73.9% | 0.00% | -100.0% |
| Q2 2021 | $48,000 | +182.4% | 1,712 | +233.1% | 0.00% | – |
| Q1 2021 | $17,000 | +142.9% | 514 | +149.5% | 0.00% | – |
| Q4 2020 | $7,000 | -93.6% | 206 | -93.6% | 0.00% | -100.0% |
| Q3 2020 | $110,000 | – | 3,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |